loadpatents
Patent applications and USPTO patent grants for Haapalinna; Antti.The latest application filed is for "treatment of epilepsy".
Patent | Date |
---|---|
Polycyclic compounds as potent alpha2-adrenoceptor antagonists Grant 7,592,350 - Belle , et al. September 22, 2 | 2009-09-22 |
Treatment of Epilepsy App 20080207719 - Haapalinna; Antti ;   et al. | 2008-08-28 |
Polycyclic compounds as potent alpha2-adrenoceptor antagonists App 20070293527 - Din Belle; David ;   et al. | 2007-12-20 |
Polycyclic compounds as potent alpha2-adrenoceptor antagonists App 20060094740 - Din Belle; David ;   et al. | 2006-05-04 |
Treatment of dependence and dependence related withdrawal symptoms App 20060058364 - Haapalinna; Antti ;   et al. | 2006-03-16 |
Prevention of development of dyskinesias App 20040039041 - Haapalinna, Antti ;   et al. | 2004-02-26 |
Derivatives of quinoline as alpha-2 antagonists App 20030225078 - Wurster, Siegfried ;   et al. | 2003-12-04 |
Method for treating sexual disorders App 20020132858 - Maki-Ikola, Outi ;   et al. | 2002-09-19 |
Treatment method App 20020115704 - Linnankoski, Ilkka ;   et al. | 2002-08-22 |
Prevention of development of dyskinesias App 20020115703 - Haapalinna, Antti ;   et al. | 2002-08-22 |
Method for treating sexual disorders App 20020099098 - Maki-Ikola, Outi ;   et al. | 2002-07-25 |
New polycyclic indanylimidazoles with alpha2 adrenergic activity App 20020013356 - Ratilainen, Jari ;   et al. | 2002-01-31 |
Imidazole derivatives App 20010056109 - Huhtala, Paavo ;   et al. | 2001-12-27 |
Derivatives of quinoline as alpha-2 antagonists App 20010046991 - Wurster, Siegfried ;   et al. | 2001-11-29 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.